EMA deal for Rinehart's new mine
EMA deal for Rinehart's new mineSydney Morning HeraldMs Rinehart's Roy Hill project will be the first to use an “EMA”, which is a new type of workplace visa devised by the Federal Government to ease chronic worker shortages in the resources sector. EMA's are only available to projects worth more than $2 ...Migration deal for Rinehart's new mineThe AustralianMigration deal for Rinehart mineBrisbane TimesGovt set to announce EMA deal with Rinehart mineBusiness Spectatorall 21 news articles »
Is this dress too short? Tooele teen gets national attention over dress-code drama
Is this dress too short? Tooele teen gets national attention over dress-code dramaDeseret NewsBy Jared Page, Deseret News Ema Parker, a Tooele Junior High student, 14, was wearing this outfit May 16, 2012, when she was reprimanded for dressing inappropriately by school officials. Her dad posted the photo on his blog and it was picked up by the ...Controversial Tooele JHS dress code violationFox 13 Now - Salt Lake Cityall 3 news articles »
EMA accepts Takeda's submission of diabetes drug alogliptin
EMA accepts Takeda's submission of diabetes drug alogliptinThe Pharma LetterNews of the EMA filing acceptance triggered a $10 million milestone payment by Takeda to USA-based drug developer Furiex Pharmaceuticals (Nasdaq: FURX). Furiex receives royalty payments from Takeda for the sale of alogliptin products, ...Takeda's diabetes drug alogliptin accepted for review by EMAPharma TimesTakeda Announces the Acceptance of the European Medicines Agency Submission of ...PipelineReview.com (press release)all 6 news articles »
EMA Declares Topaz Ranch Estates Fire Major Disaster
EMA Declares Topaz Ranch Estates Fire Major DisasterKRNV My News 4(Washington, DC) – The Federal Emergency Management Agency (FEMA) has declared the Topaz Ranch Estates fire a major disaster. This decision makes the region eligible for assistance in the mitigation, management, and control of burning on publicly and ...and more »
Gilead Drug Up for European Review
Gilead Drug Up for European ReviewZacks.comRecently, Gilead Sciences, Inc. (GILD - Analyst Report) announced that its marketing application seeking approval for its candidate cobicistat in the EU has been validated by the European Medicines Agency (EMA). Cobicistat acts as a “boosting” agent ...and more »